Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$33.32 USD
-0.20 (-0.60%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $33.38 +0.06 (0.18%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Harmony Biosciences (HRMY) reported earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.64 per share. This reflects a positive earnings surprise of 4.69%. Look out for HRMY's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year decrease of 107.14%.
Earnings History
Price & Consensus
Zacks News for HRMY
Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
HRMY: What are Zacks experts saying now?
Zacks Private Portfolio Services